REVO Insurance (REVO) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
7 Oct, 2025Executive summary
Gross written premiums reached €216.9 million, up 45.5% year-over-year, with all business lines growing except Agro, which was selectively underwritten for profitability.
Adjusted operating profit was €26.4 million and adjusted net profit €17.0 million, both exceeding full-year 2023 results.
The company confirmed its ambition to reach €300 million in premiums and over €20 million in adjusted net profit by year-end.
Strategic initiatives included AI adoption (Luminate), expansion of the OverX platform, and the launch of the Spanish branch (REVO Iberia).
Financial highlights
Revenues from insurance contracts were €161.3 million, up from €107.0 million year-over-year.
Result of insurance services was €23.2 million, with a net financial result of €3.2 million.
IFRS 17 combined ratio was 84.9%, slightly higher than 82.3% in Q3 2023 but improved from 85.8% at year-end 2023.
Group equity stood at €240.0 million as of 30 September 2024.
Outlook and guidance
The company aims to reach €300 million in premiums and over €20 million in adjusted net profit for the full year.
Focus remains on technology and operational projects, with the operational launch of the Spanish branch expected in Q4.
Latest events from REVO Insurance
- Premiums up 52.5%, net profit up 50%, with strong ratios and robust capital position.REVO
H1 202425 Jan 2026 - Premiums up 42.8%, net profit €22.6M, targets beat early, and dividend rises to €0.22.REVO
H2 20247 Jan 2026 - AI-driven plan targets €550M+ GWP, €50M+ profit, and specialty line growth by 2028.REVO
Investor Day 20256 Jan 2026 - Premiums up 31%, adjusted profit €25.8M, net profit €11.3M, Solvency II ratio 245.2%.REVO
H1 20256 Jan 2026 - Premiums up 29.4%, adjusted net profit €24.2M, and strong capital position support growth.REVO
Q3 20256 Nov 2025 - Premiums up 40.7%, adjusted operating profit up 18.4%, Solvency II ratio at 246.6%.REVO
Q1 20257 Oct 2025